Felicity N. E. Gavins

Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse.

Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms.

Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor.

Annexin 1: an endogenous anti-inflammatory protein.

Intravital microscopy for the study of mouse microcirculation in anti-inflammatory drug research: focus on the mesentery and cremaster preparations.

Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct.

[D-Trp8]-gamma-melanocyte-stimulating hormone exhibits anti-inflammatory efficacy in mice bearing a nonfunctional MC1R (recessive yellow e/e mouse).

Stem/progenitor cell-like properties of desmoglein 3dim cells in primary and immortalized keratinocyte lines.

Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation.

Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion.

Annexin A1 and the formyl peptide receptor family: neuroendocrine and metabolic aspects.

Troubleshooting methods: Using intravital microscopy in drug research.

Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury?

Targeting the melanocortin receptor system for anti-stroke therapy.

Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S.

Modeling inflammation and microvascular dysfunction.

The peritoneal tumour microenvironment of high-grade serous ovarian cancer.

The potential of stem cell therapy for stroke: is PISCES the sign?

Role and interactions of annexin A1 and oestrogens in the manifestation of sexual dimorphisms in cerebral and systemic inflammation.

New technologies: only a snapshot, but look how far we have come!

Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system.

Intravital microscopy: new insights into cellular interactions.

Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.

Annexin A1 and the regulation of innate and adaptive immunity.

Phytochemicals: countering risk factors and pathological responses associated with ischaemia reperfusion injury.

(99m)Tc SPECT imaging agent based on cFLFLFK for the detection of FPR1 in inflammation.

Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke.

Targeting the annexin 1-formyl peptide receptor 2/ALX pathway affords protection against bacterial LPS-induced pathologic changes in the murine adrenal cortex.

Critical differences between two classical surgical approaches for middle cerebral artery occlusion-induced stroke in mice.

Cell tracking technologies for acute ischemic brain injury.

Both MC1 and MC3 Receptors Provide Protection From Cerebral Ischemia-Reperfusion-Induced Neutrophil Recruitment.

Modeling Ischemic Stroke In Vitro: Status Quo and Future Perspectives.

A Critical Role for Monocytes/Macrophages During Intestinal Inflammation-associated Lymphangiogenesis.

Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.

Sulforaphane induces neurovascular protection against a systemic inflammatory challenge via both Nrf2-dependent and independent pathways.